Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Atara Biotherapeutics Inc (ATRA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q4 | 0 | 0.00 | Sell 100.00% | 0.21 | SEC | ||
| 2023 Q3 | 6,290,713 | 0.21 | $1.48 | $9,310,255 | SEC | ||
| 2023 Q2 | 6,290,713 | 0.22 | $1.61 | $10,128,048 | SEC | ||
| 2023 Q1 | 6,290,713 | 0.46 | Reduce 0.00% | $2.90 | $18,243,068 | SEC | |
| 2022 Q4 | 6,291,013 | 0.49 | Reduce 19.92% | 0.13 | $3.28 | $20,634,523 | SEC |
| 2022 Q3 | 7,855,824 | 0.67 | $3.78 | $29,695,000 | SEC | ||
| 2022 Q2 | 7,855,824 | 1.52 | $7.79 | $61,197,000 | SEC | ||
| 2022 Q1 | 7,855,824 | 1.33 | $9.29 | $72,981,000 | SEC | ||
| 2021 Q4 | 7,855,824 | 1.41 | $15.76 | $123,808,000 | SEC | ||
| 2021 Q3 | 7,855,824 | 1.43 | Add 1.96% | 0.03 | $17.90 | $140,619,000 | SEC |
| 2021 Q2 | 7,704,676 | 1.14 | Add 14.32% | 0.14 | $15.55 | $119,808,000 | SEC |
| 2021 Q1 | 6,739,402 | 0.88 | Reduce 7.99% | 0.18 | $14.36 | $96,778,000 | SEC |
| 2020 Q4 | 7,324,539 | 2.30 | Add 8.57% | 0.18 | $19.63 | $143,781,000 | SEC |
| 2020 Q3 | 6,746,292 | 1.63 | Reduce 0.12% | <0.01 | $12.96 | $87,432,000 | SEC |
| 2020 Q2 | 6,754,102 | 2.07 | Add 29.89% | 0.48 | $14.57 | $98,407,000 | SEC |
| 2020 Q1 | 5,199,897 | 0.93 | Add 4.87% | 0.04 | $8.51 | $44,251,000 | SEC |
| 2019 Q4 | 4,958,431 | 1.19 | Reduce 2.85% | 0.03 | $16.47 | $81,665,000 | SEC |
| 2019 Q3 | 5,103,963 | 1.06 | Add 128.62% | 0.60 | $14.12 | $72,068,000 | SEC |
| 2019 Q2 | 2,232,476 | 0.65 | Add 156.38% | 0.40 | $20.11 | $44,895,000 | SEC |
| 2019 Q1 | 870,764 | 0.47 | Buy | 0.47 | $39.75 | $34,613,000 | SEC |